Literature DB >> 2715170

Different effects of cyclophosphamide in vivo and phosphamide mustard in vitro on two cell clones of chemically induced mammary carcinoma of the rat.

G Angres1, H R Scherf.   

Abstract

Two cell clones of a methylnitrosourea-induced rat mammary carcinoma, a hyperdiploid (44 chromosomes, clone A) and a hypertetraploid clone (88 chromosomes, clone B) were cultured and transplanted subcutaneously into three groups of eight rats. Group 1 was treated with 62.6 mg cyclophosphamide/kg, group 2 with 41.8 mg/kg once weekly for 3 weeks. The volume of tumors derived from clone B cells was diminished by the administration of the agent, whereas clone A cell tumors did not respond. Incubation of cells of both clones with phosphamide mustard in vitro showed that cells of clone B are much more sensitive to the activated cyclophosphamide, especially after incubation in low concentrations of 40 microM and 20 microM, than those of clone A. It is concluded that the initial success of cyclophosphamide therapy on chemically induced tumors is due to the different sensitivities of the tumor cell populations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715170     DOI: 10.1007/BF00397925

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  4 in total

1.  The heterogenous cytotoxic response of colon cancer cells is unrelated to phenotypic differentiation characteristics.

Authors:  B Drewinko; L Y Yang
Journal:  Anticancer Res       Date:  1988 Jan-Feb       Impact factor: 2.480

Review 2.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

Review 3.  Intraneoplastic diversity.

Authors:  D L Dexter; P Calabresi
Journal:  Biochim Biophys Acta       Date:  1982-12-21

4.  Noncarcinogenic chemotherapy with a combination of vincristine, methotrexate and 5-fluorouracil (VMF) in rats.

Authors:  M Berger; M Habs; D Schmähl
Journal:  Int J Cancer       Date:  1983-08-15       Impact factor: 7.396

  4 in total
  3 in total

1.  Sensitivity of rodent osteosarcoma clones to platinum-containing phosphonic acid complexes in vitro.

Authors:  T Klenner; P Valenzuela-Paz; B K Keppler; H R Scherf
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Hexadecylphosphocholine differs from conventional cytostatic agents.

Authors:  M R Berger; B Betsch; M Gebelein; E Amtmann; P Heyl; H R Scherf
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.

Authors:  S B Sobottka; M R Berger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.